Original
Perfil clínico y curso evolutivo de los pacientes tratados con efalizumab tras la suspensión de su autorización por la EMEA. Estudio observacional y multicéntrico
Clinical Characteristics and Disease Course in Patients Treated With Efalizumab Following Suspension of Marketing Authorization by the European Medicines Agency: A Multicenter Observational Study
L. Morella,
, J.M. Carrascosaa, C. Ferrándiza, M. García-Bustinduyb, E. Fonsecac, G. Carreterod, E. Daudéne, S.E. Marrónf, J.L. López-Estebaranzg, M. Ferránh, M. Sánchez-Regañai, C. Muñoz-Santosj, I. Belinchónk, Luis Puigl, Grupo Español de Psoriasis
Autor para correspondencia
a Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España
b Servicio de Dermatología, Hospital Universitario de Canarias, Islas Canarias, España
c Servicio de Dermatología, Hospital Juan Canalejo, La Coruña, España
d Servicio de Dermatología, Hospital Universitario de Canarias Dr. Negrín, Islas Canarias, España
e Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, España
f Servicio de Dermatología, Hospital de Calatayud, Instituto Aragonés de Ciencias de la Salud, Zaragoza, España
g Servicio de Dermatología, Hospital de Alcorcón, Madrid, España
h Servicio de Dermatología, Hospital del Mar, Barcelona, España
i Servicio de Dermatología, Hospital del Sagrat Cor, Barcelona, España
j Servicio de Dermatología, Hospital Clínic i Provincial, Barcelona, España
k Servicio de Dermatología, Hospital General de Alicante, Alicante, España
l Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, España
Ver másLeído
8681
Vecesse ha leído el artículo
2581
Total PDF
6100
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 15 | 6 | 21 |
| 2025 5 | 90 | 33 | 123 |
| 2025 4 | 76 | 32 | 108 |
| 2025 3 | 51 | 11 | 62 |
| 2025 2 | 109 | 31 | 140 |
| 2025 1 | 50 | 33 | 83 |
| 2024 12 | 42 | 22 | 64 |
| 2024 11 | 46 | 45 | 91 |
| 2024 10 | 42 | 35 | 77 |
| 2024 9 | 39 | 27 | 66 |
| 2024 8 | 55 | 64 | 119 |
| 2024 7 | 36 | 26 | 62 |
| 2024 6 | 59 | 34 | 93 |
| 2024 5 | 51 | 30 | 81 |
| 2024 4 | 73 | 30 | 103 |
| 2024 3 | 45 | 24 | 69 |
| 2024 2 | 45 | 26 | 71 |
| 2024 1 | 56 | 28 | 84 |
| 2023 12 | 49 | 15 | 64 |
| 2023 11 | 70 | 25 | 95 |
| 2023 10 | 48 | 20 | 68 |
| 2023 9 | 32 | 23 | 55 |
| 2023 8 | 24 | 14 | 38 |
| 2023 7 | 36 | 30 | 66 |
| 2023 6 | 29 | 46 | 75 |
| 2023 5 | 28 | 15 | 43 |
| 2023 4 | 22 | 21 | 43 |
| 2023 3 | 80 | 16 | 96 |
| 2023 2 | 66 | 19 | 85 |
| 2022 1 | 34 | 23 | 57 |
| 2022 12 | 63 | 26 | 89 |
| 2022 11 | 82 | 46 | 128 |
| 2022 10 | 69 | 35 | 104 |
| 2022 9 | 61 | 44 | 105 |
| 2022 8 | 56 | 50 | 106 |
| 2022 7 | 52 | 48 | 100 |
| 2022 6 | 54 | 30 | 84 |
| 2022 5 | 59 | 47 | 106 |
| 2022 4 | 48 | 34 | 82 |
| 2022 3 | 51 | 55 | 106 |
| 2022 2 | 32 | 23 | 55 |
| 2021 1 | 44 | 43 | 87 |
| 2021 12 | 30 | 46 | 76 |
| 2021 11 | 55 | 37 | 92 |
| 2021 10 | 63 | 53 | 116 |
| 2021 9 | 46 | 29 | 75 |
| 2021 8 | 26 | 25 | 51 |
| 2021 7 | 44 | 24 | 68 |
| 2021 6 | 48 | 44 | 92 |
| 2021 5 | 38 | 17 | 55 |
| 2021 4 | 75 | 28 | 103 |
| 2021 3 | 115 | 17 | 132 |
| 2021 2 | 108 | 35 | 143 |
| 2020 1 | 67 | 25 | 92 |
| 2020 12 | 37 | 19 | 56 |
| 2020 11 | 39 | 14 | 53 |
| 2020 10 | 38 | 10 | 48 |
| 2020 9 | 48 | 8 | 56 |
| 2020 8 | 31 | 17 | 48 |
| 2020 7 | 27 | 12 | 39 |
| 2020 6 | 34 | 19 | 53 |
| 2020 5 | 33 | 20 | 53 |
| 2020 4 | 46 | 21 | 67 |
| 2020 3 | 39 | 10 | 49 |
| 2020 2 | 4 | 0 | 4 |
| 2019 12 | 3 | 2 | 5 |
| 2019 9 | 6 | 2 | 8 |
| 2019 6 | 0 | 16 | 16 |
| 2019 5 | 2 | 16 | 18 |
| 2019 4 | 0 | 4 | 4 |
| 2019 3 | 0 | 4 | 4 |
| 2019 2 | 2 | 2 | 4 |
| 2019 1 | 0 | 2 | 2 |
| 2018 12 | 3 | 2 | 5 |
| 2018 11 | 4 | 0 | 4 |
| 2018 10 | 1 | 2 | 3 |
| 2018 9 | 1 | 1 | 2 |
| 2018 7 | 1 | 0 | 1 |
| 2018 5 | 0 | 8 | 8 |
| 2018 4 | 0 | 1 | 1 |
| 2018 3 | 4 | 0 | 4 |
| 2018 2 | 31 | 3 | 34 |
| 2018 1 | 31 | 6 | 37 |
| 2017 12 | 41 | 4 | 45 |
| 2017 11 | 46 | 3 | 49 |
| 2017 10 | 45 | 6 | 51 |
| 2017 9 | 51 | 5 | 56 |
| 2017 8 | 59 | 4 | 63 |
| 2017 7 | 54 | 3 | 57 |
| 2017 6 | 66 | 11 | 77 |
| 2017 5 | 48 | 15 | 63 |
| 2017 4 | 54 | 6 | 60 |
| 2017 3 | 43 | 8 | 51 |
| 2017 2 | 30 | 7 | 37 |
| 2016 1 | 22 | 8 | 30 |
| 2016 12 | 49 | 9 | 58 |
| 2016 11 | 73 | 6 | 79 |
| 2016 10 | 62 | 21 | 83 |
| 2016 9 | 102 | 15 | 117 |
| 2016 8 | 53 | 12 | 65 |
| 2016 7 | 34 | 11 | 45 |
| 2016 6 | 9 | 6 | 15 |
| 2016 5 | 9 | 7 | 16 |
| 2016 4 | 4 | 3 | 7 |
| 2016 3 | 6 | 2 | 8 |
| 2016 2 | 4 | 3 | 7 |
| 2015 1 | 5 | 14 | 19 |
| 2015 12 | 7 | 16 | 23 |
| 2015 11 | 11 | 14 | 25 |
| 2015 10 | 9 | 14 | 23 |
| 2015 9 | 14 | 6 | 20 |
| 2015 8 | 12 | 6 | 18 |
| 2015 7 | 61 | 1 | 62 |
| 2015 6 | 41 | 5 | 46 |
| 2015 5 | 81 | 18 | 99 |
| 2015 4 | 64 | 8 | 72 |
| 2015 3 | 47 | 7 | 54 |
| 2015 2 | 37 | 7 | 44 |
| 2015 1 | 54 | 9 | 63 |
| 2014 12 | 69 | 5 | 74 |
| 2014 11 | 58 | 10 | 68 |
| 2014 10 | 59 | 13 | 72 |
| 2014 9 | 46 | 12 | 58 |
| 2014 8 | 55 | 20 | 75 |
| 2014 7 | 53 | 19 | 72 |
| 2014 6 | 65 | 8 | 73 |
| 2014 5 | 84 | 22 | 106 |
| 2014 4 | 61 | 11 | 72 |
| 2014 3 | 79 | 12 | 91 |
| 2014 2 | 55 | 16 | 71 |
| 2014 1 | 68 | 21 | 89 |
| 2013 12 | 79 | 19 | 98 |
| 2013 11 | 63 | 20 | 83 |
| 2013 10 | 79 | 21 | 100 |
| 2013 9 | 50 | 27 | 77 |
| 2013 8 | 62 | 28 | 90 |
| 2013 7 | 75 | 41 | 116 |
| 2013 6 | 58 | 32 | 90 |
| 2013 5 | 20 | 9 | 29 |
| 2013 4 | 13 | 5 | 18 |
| 2013 3 | 12 | 8 | 20 |
| 2013 2 | 37 | 4 | 41 |
| 2013 1 | 20 | 4 | 24 |
| 2012 12 | 16 | 5 | 21 |
| 2012 10 | 2 | 1 | 3 |
| 2012 9 | 0 | 1 | 1 |
| 2012 8 | 0 | 1 | 1 |
| 2011 5 | 6 | 0 | 6 |
Mostrar todo
